Oral peptides and uses thereof for weight loss, weight maintenance, and management of metabolic conditions

TW202635716APending Publication Date: 2026-09-01METSERA INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114144887
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-18
Filing Date
2025-11-18
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074704_001
    Figure TWG2TA001074704_001
  • Figure TWG2TA001074704_002
    Figure TWG2TA001074704_002
  • Figure TWG2TA001074704_003
    Figure TWG2TA001074704_003
Patent Text Reader

Abstract

The present disclosure provides peptides for reducing weight and / or preventing weight gain comprising a GLP-1R agonist. As described herein, the GLP-1R agonist can be administered orally to a subject.
Need to check novelty before this filing date? Find Prior Art